- Enfusion Inc.
Enfusion Inc.
125 South Clark Street
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$17.00
18,800,000
Positive
High
70.53%
Offering Team
Deal Managers
- Morgan Stanley
- Goldman Sachs
- Bank of America Merrill Lynch
Lawyers
- Davis Polk & Wardwell LLP
Auditors
- Ernst & Young LLP
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
Enfusion is a global, high-growth software-as-a-service, or SaaS, provider focused on transforming the investment management industry. Our solution is designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time. We simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source More
Deal Tracker
Investors
Filing
20 Oct, 2021Offer
21 Oct, 2021Look Ahead
Lock Up Expiry
21 Apr, 2022Earning
Nov 1, 2018IPO Terms
| Offer Price | $17.00 |
| Offer Size | 18M |
